Baird upgrades Pool Corp to Outperform, citing cyclical recovery and resilient discretionary spending in the pool and outdoor living sector, with a price target of $320.
Despite plunging to multi-year lows, Litecoin is seeing sustained demand from payment gateways, privacy features, and long-term accumulation, suggesting a potential foundation for recovery amid a brutal market.
A landmark $100 million in tokenized real-world assets on the XDC Network, led by fintech Liqi, signals Brazil's shift from blockchain pilots to institutional-scale adoption, outpacing many developed economies.
The French wine group, home to labels like Lanson and Philipponnat, saw revenue fall nearly 9% in 2025, underperforming a declining Champagne market as economic pressures and promotional battles squeeze margins.
Despite processing over $8.4 trillion in January—dwarfing traditional card networks—Circle's share price continues its steep decline, highlighting a stark divide between booming on-chain utility and skeptical market valuation.
Dubai's Roads and Transport Authority announces immediate commencement of the initial 6km segment of the 24km 'Dubai Loop', a high-speed underground transport system developed in partnership with Elon Musk's Boring Company, with an estimated total project cost of $681 million.
Despite respectable revenue growth, shareholders in the payment solutions provider have seen their investment erode by 87% over half a decade, highlighting the perils of holding onto underperforming stocks.
While the broader real estate market has rallied, investors in Armada Hoffler Properties (NYSE: AHH) have seen their holdings decline sharply over a three-year period, with total shareholder returns lagging far behind market averages. We examine the fundamentals behind the underperformance.
A new discounted cash flow analysis suggests Select Water Solutions' stock is trading at a significant discount to its estimated intrinsic value, with potential political tailwinds from the upcoming election adding to the investment thesis.
Twin Disc, Incorporated announces a $0.04 per share dividend payable in March, but a history of cuts and a high earnings payout ratio raise flags for income-focused investors.
A new analysis reveals that Costco's discounted gasoline can more than offset the annual membership cost for drivers in major U.S. cities, with savings varying dramatically by location.
A landmark shift in bankruptcy policy has dramatically improved success rates for student loan borrowers seeking discharge. Despite its efficacy, experts warn that a critical lack of awareness and lingering skepticism among attorneys is preventing a debt-laden generation from accessing this vital lifeline.
The Trump administration launches a major public-private initiative to stockpile essential minerals, aiming to shield U.S. manufacturers from supply shocks and reduce strategic dependence on China.
Tesla's full-year 2025 results show a sharp 46% decline in net income, marking a second consecutive year of falling profits as EV competition intensifies and the company accelerates its shift toward AI and robotics.
Himax Technologies' stock has declined 9% over the past quarter, prompting a closer look at its underlying financial health. A low Return on Equity and high dividend payout ratio raise questions about its growth trajectory in a competitive semiconductor landscape.
Elon Musk's artificial intelligence venture, xAI, is recruiting remote cryptocurrency finance specialists. The move aims to deepen its AI models' understanding of digital asset markets, moving beyond price prediction to grasp trading behavior, on-chain analytics, and risk management.
BMO Capital has increased its price target for Allstate (NYSE: ALL) from $244 to $249, maintaining a Buy rating. The firm points to lower catastrophe losses and a significant drop in reinsurance costs as key drivers for improved earnings visibility through 2026/27.
Goldman Sachs maintains a Neutral stance on Pfizer (PFE) with a $26 price target, as the pharmaceutical giant navigates significant margin pressures from looming patent expiries and a constrained business development budget.
Despite recent market turbulence triggered by Medicare Advantage rate announcements, Bernstein reaffirms its confidence in UnitedHealth Group with a $405 price target, even as another major firm adopts a more cautious stance.
FirstEnergy shares have delivered robust returns over the past year, climbing 22%. Yet, a closer look reveals a valuation puzzle: while some models flag overvaluation, others suggest hidden value. We examine the conflicting signals and what they mean for investors considering this utility giant.
